Maintenance and replication of the human cytomegalovirus genome during latency.

[1]  H. Kalbitzer,et al.  Human Cytomegalovirus Major Immediate Early 1 Protein Targets Host Chromosomes by Docking to the Acidic Pocket on the Nucleosome Surface , 2013, Journal of Virology.

[2]  Christopher G. Abraham,et al.  Polycomb Repressive Complex 2 Silences Human Cytomegalovirus Transcription in Quiescent Infection Models , 2013, Journal of Virology.

[3]  K. Kaye,et al.  Identification of Kaposi's Sarcoma-Associated Herpesvirus LANA Regions Important for Episome Segregation, Replication, and Persistence , 2013, Journal of Virology.

[4]  C. Rossetto,et al.  Cis and Trans Acting Factors Involved in Human Cytomegalovirus Experimental and Natural Latent Infection of CD14 (+) Monocytes and CD34 (+) Cells , 2013, PLoS pathogens.

[5]  S. Verma,et al.  Kaposi's Sarcoma-Associated Herpesvirus-Encoded LANA Recruits Topoisomerase IIβ for Latent DNA Replication of the Terminal Repeats , 2012, Journal of Virology.

[6]  Jae U. Jung,et al.  Negative Elongation Factor-Mediated Suppression of RNA Polymerase II Elongation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Gene Expression , 2012, Journal of Virology.

[7]  Eui Tae Kim,et al.  The chromatin-tethering domain of human cytomegalovirus immediate-early (IE) 1 mediates associations of IE1, PML and STAT2 with mitotic chromosomes, but is not essential for viral replication. , 2012, The Journal of general virology.

[8]  T. Kadowaki,et al.  Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity , 2011, The Journal of experimental medicine.

[9]  M. West,et al.  RNA Polymerase II Stalling Promotes Nucleosome Occlusion and pTEFb Recruitment to Drive Immortalization by Epstein-Barr Virus , 2011, PLoS pathogens.

[10]  K. Akashi,et al.  Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. , 2011, Cancer cell.

[11]  J. Maciejewski,et al.  Human cytomegalovirus latency-associated protein LUNA is expressed during HCMV infections in vivo , 2011, Archives of Virology.

[12]  Jun Seita,et al.  Hematopoietic stem cell: self‐renewal versus differentiation , 2010, Wiley interdisciplinary reviews. Systems biology and medicine.

[13]  G. Pari,et al.  Nucleocytoplasmic Shuttling of Human Cytomegalovirus UL84 Is Essential for Virus Growth , 2010, Journal of Virology.

[14]  L. Frappier,et al.  Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2) , 2009, Journal of Cell Science.

[15]  C. Paulus,et al.  Physical Requirements and Functional Consequences of Complex Formation between the Cytomegalovirus IE1 Protein and Human STAT2 , 2009, Journal of Virology.

[16]  L. Frappier,et al.  Nucleosome Assembly Proteins Bind to Epstein-Barr Virus Nuclear Antigen 1 and Affect Its Functions in DNA Replication and Transcriptional Activation , 2009, Journal of Virology.

[17]  Eui Tae Kim,et al.  Binding STAT2 by the Acidic Domain of Human Cytomegalovirus IE1 Promotes Viral Growth and Is Negatively Regulated by SUMO , 2008, Journal of Virology.

[18]  Leonard I. Zon,et al.  Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal , 2008, Nature.

[19]  B. Slobedman,et al.  Immunomodulatory Properties of a Viral Homolog of Human Interleukin-10 Expressed by Human Cytomegalovirus during the Latent Phase of Infection , 2008, Journal of Virology.

[20]  M. Reeves,et al.  Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. , 2007, Blood.

[21]  Carlo Riccardi,et al.  Analysis of apoptosis by propidium iodide staining and flow cytometry , 2006, Nature Protocols.

[22]  T. Stamminger,et al.  Evidence for a Role of the Cellular ND10 Protein PML in Mediating Intrinsic Immunity against Human Cytomegalovirus Infections , 2006, Journal of Virology.

[23]  K. Luger,et al.  Kaposi’s Sarcoma-Associated Herpesvirus LANA Hitches a Ride on the Chromosome , 2006, Cell cycle.

[24]  C. Paulus,et al.  A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Lehner,et al.  An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. , 2005, The Journal of general virology.

[26]  J. Maciejewski,et al.  Characterization of an Antisense Transcript Spanning the UL81-82 Locus of Human Cytomegalovirus , 2005, Journal of Virology.

[27]  J. Azizkhan-Clifford,et al.  The Carboxyl-Terminal Region of Human Cytomegalovirus IE1491aa Contains an Acidic Domain That Plays a Regulatory Role and a Chromatin-Tethering Domain That Is Dispensable during Viral Replication , 2005, Journal of Virology.

[28]  William Stedman,et al.  ORC, MCM, and Histone Hyperacetylation at the Kaposi's Sarcoma-Associated Herpesvirus Latent Replication Origin , 2004, Journal of Virology.

[29]  Mark J. Murphy,et al.  c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. , 2004, Genes & development.

[30]  J. Maciejewski,et al.  Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form , 2004, British journal of haematology.

[31]  I. Weissman,et al.  A role for Wnt signalling in self-renewal of haematopoietic stem cells , 2003, Nature.

[32]  F. Goodrum,et al.  Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: A model for latency , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  C. Lim,et al.  Functional Dissection of Latency-Associated Nuclear Antigen 1 of Kaposi's Sarcoma-Associated Herpesvirus Involved in Latent DNA Replication and Transcription of Terminal Repeats of the Viral Genome , 2002, Journal of Virology.

[34]  K. Yanagi,et al.  Epstein-Barr virus nuclear antigen-1 is highly colocalized with interphase chromatin and its newly replicated regions in particular. , 2002, The Journal of general virology.

[35]  M. Wills,et al.  Latency and reactivation of human cytomegalovirus. , 2002, The Journal of infection.

[36]  E. Robertson,et al.  The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus. , 2001, Virology.

[37]  T. Fujita,et al.  Amino Acid Substitution Analyses of the DNA Contact Region, Two Amphipathic α-Helices and a Recognition-Helix-Like Helix outside the Dimeric β-Barrel of Epstein-Barr Virus Nuclear Antigen 1 , 2001, Intervirology.

[38]  Jianhong Hu,et al.  DNA Binding and Modulation of Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.

[39]  H. Xu,et al.  Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein–Barr virus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  E. Kremmer,et al.  Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein–Barr virus , 2001, The EMBO journal.

[41]  Anindya Dutta,et al.  Replication from oriP of Epstein-Barr Virus Requires Human ORC and Is Inhibited by Geminin , 2001, Cell.

[42]  B. Sugden,et al.  Establishment of an oriP Replicon Is Dependent upon an Infrequent, Epigenetic Event , 2001, Molecular and Cellular Biology.

[43]  T. Piolot,et al.  Close but Distinct Regions of Human Herpesvirus 8 Latency-Associated Nuclear Antigen 1 Are Responsible for Nuclear Targeting and Binding to Human Mitotic Chromosomes , 2001, Journal of Virology.

[44]  M. Ballestas,et al.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 Mediates Episome Persistence through cis-Acting Terminal Repeat (TR) Sequence and Specifically Binds TR DNA , 2001, Journal of Virology.

[45]  G. Hayward,et al.  Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. , 2000, Virology.

[46]  L. Frappier,et al.  Functional Analyses of the EBNA1 Origin DNA Binding Protein of Epstein-Barr Virus , 2000, Journal of Virology.

[47]  J. Yates,et al.  The Minimal Replicator of Epstein-Barr VirusoriP , 2000, Journal of Virology.

[48]  S. Pestka,et al.  Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[49]  E. Robertson,et al.  The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. , 1999, Virology.

[50]  T. Piolot,et al.  Mapping EBNA-1 Domains Involved in Binding to Metaphase Chromosomes , 1999, Journal of Virology.

[51]  M. Ballestas,et al.  Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. , 1999, Science.

[52]  J. Maciejewski,et al.  Human cytomegalovirus infection of human hematopoietic progenitor cells. , 1999, Leukemia & lymphoma.

[53]  A. Aiyar,et al.  The plasmid replicon of EBV consists of multiple cis‐acting elements that facilitate DNA synthesis by the cell and a viral maintenance element , 1998, The EMBO journal.

[54]  E. Brignole,et al.  Disruption of PML Subnuclear Domains by the Acidic IE1 Protein of Human Cytomegalovirus Is Mediated through Interaction with PML and May Modulate a RING Finger-Dependent Cryptic Transactivator Function of PML , 1998, Molecular and Cellular Biology.

[55]  G. Wilkinson,et al.  Disruption of PML-associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product. , 1998, The Journal of general virology.

[56]  W. Piacibello,et al.  Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation , 1998, Leukemia.

[57]  E. Mocarski,et al.  Defective Growth Correlates with Reduced Accumulation of a Viral DNA Replication Protein after Low-Multiplicity Infection by a Human Cytomegalovirus ie1 Mutant , 1998, Journal of Virology.

[58]  K. Fish,et al.  Reactivation of Latent Human Cytomegalovirus by Allogeneic Stimulation of Blood Cells from Healthy Donors , 1997, Cell.

[59]  J. Maciejewski,et al.  Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: model of HCMV latency. , 1997, Blood.

[60]  E. Huang,et al.  Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters , 1997, Journal of virology.

[61]  G. Hayward,et al.  The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells , 1997, Journal of virology.

[62]  J. Sinclair,et al.  Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. , 1996, The Journal of general virology.

[63]  B. Plachter,et al.  The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. , 1996, Experimental cell research.

[64]  S. Chou,et al.  A single G-to-C change causes human centromere TGGAA repeats to fold back into hairpins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[65]  J. Xu,et al.  Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[66]  S. Chou,et al.  The structure of a novel DNA duplex formed by human centromere d(TGGAA) repeats with possible implications for chromosome attachment during mitosis. , 1995, Journal of molecular biology.

[67]  N. Young,et al.  Infection of hematopoietic progenitor cells by human cytomegalovirus. , 1992, Blood.

[68]  K. Yoda,et al.  Centromere protein B assembles human centromeric alpha-satellite DNA at the 17-bp sequence, CENP-B box , 1992, The Journal of cell biology.

[69]  C. Koller,et al.  Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. , 1991, The Journal of clinical investigation.

[70]  J. Sissons,et al.  Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. , 1991, The Journal of general virology.

[71]  R. Snyder,et al.  Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. , 1991, Biochemistry.

[72]  G. Hayward,et al.  Expression of the acidic nuclear immediate-early protein (IE1) of human cytomegalovirus in stable cell lines and its preferential association with metaphase chromosomes. , 1989, Virology.

[73]  W. Britt,et al.  A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus. , 1989, Journal of virological methods.

[74]  W. Britt,et al.  Structural and immunological characterization of the intracellular forms of an abundant 68,000 Mr human cytomegalovirus protein. , 1987, The Journal of general virology.

[75]  Can Alkan,et al.  Genome-wide characterization of centromeric satellites from multiple mammalian genomes. , 2011, Genome research.

[76]  T. Reya.  Regulation of hematopoietic stem cell self-renewal. , 2003, Recent progress in hormone research.

[77]  C. Collins,et al.  Genetic requirements for the episomal maintenance of oncogenic herpesvirus genomes. , 2002, Advances in cancer research.

[78]  E. Mocarski,et al.  Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. , 1999, Blood.

[79]  J. Sinclair,et al.  Latent and persistent infections of monocytes and macrophages. , 1996, Intervirology.

[80]  E. Mocarski,et al.  Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. , 1995, Scandinavian journal of infectious diseases. Supplementum.